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Introduction
Anxiety is evident more often in individuals with intellec-
tual disability than those of typical development. Preva-
lence rates for an anxiety disorder in children and adoles-
cents with an intellectual disability range from 3 to 21.9% 
(Reardon et  al. 2015; Royston et  al. 2016). These preva-
lence rates are higher than those for the general popula-
tion for which the prevalence rate for typically developing 
children and adolescents is 3 to 6.5% (Green et  al. 2005; 
Polanczyk et al. 2015). DSM-5 lists 12 types of anxiety dis-
order (American Psychiatric Association 2013): separation 
anxiety disorder, selective mutism, specific phobia, social 
anxiety disorder, panic disorder, panic attack, agoraphobia, 
generalized anxiety disorder, substance-induced anxiety 
disorder, anxiety disorder due to another medical condition, 
other specified anxiety disorder and unspecified anxiety 
disorder.
Genetic syndromes can be associated with a height-
ened prevalence of particular characteristics (Dykens et al. 
2000); for example, heightened levels of self-injurious 
behavior in Lesch–Nyhan syndrome, aggression in Angel-
man syndrome and excessive friendliness in Williams syn-
drome (see Waite et  al. 2014 for a review). Furthermore, 
research has indicated that some genetic syndromes, such 
as Williams syndrome, 22q11.2 deletion, fragile X (FXS) 
and Cornelia de Lange syndrome (CdLS), are also at 
greater risk of anxiety compared to the general population 
(CdLS: Basile et al. 2007; FXS: Cordeiro et al. 2011; Wil-
liams syndrome: Dykens 2003; 22q deletion: Fung et  al. 
2010). These genetic syndromes are often associated with 
specific types of anxiety disorder. For example, anxiety in 
people with Williams syndrome is more likely to be gen-
eralized, or related to specific phobias and fears, than to 
social situations (Leyfer et al. 2009).
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Anxiety has previously been investigated in FXS, CdLS 
and Rubinstein–Taybi syndromes (RTS), which form the 
focus of the current study. Although previous research has 
suggested a heightened risk of anxiety in these populations, 
this research has not explored the symptoms of different 
types of anxiety disorder using comparable assessment 
instruments. Identifying the symptomatology of differ-
ent types of anxiety disorder most associated with these 
genetic syndromes will further understanding of the diffi-
culties experienced by these groups. This will provide valu-
able information to clinicians, aiding them in developing 
early intervention strategies and targeted syndrome-sensi-
tive interventions.
The aim of the present study is to delineate the profile 
of anxiety symptomatology in individuals with FXS, CdLS 
and RTS. To aid interpretation, the symptomatology of 
anxiety disorders in these genetic syndromes will be com-
pared to normative data from samples of typically devel-
oping children, and children who have received a clinical 
diagnosis of an anxiety disorder.
Fragile X Syndrome
FXS affects approximately 1 in 2500–5000 males and 1 in 
4000–6000 females (Coffee et al. 2009; Hirst et al. 1993), 
and is caused by abnormalities in the Fragile X Mental 
Retardation 1 (FMR1) gene located at Xq27.3, resulting 
in excessive cytosine–guanine–guanine (CGG) repeats and 
reduced production of the FMRP protein. As an X-linked 
disorder, males with the full mutation of FXS are more 
severely affected than females, and due to these gender dif-
ferences, males form the focus of this study. A recent meta-
analysis indicated that approximately 30% of males with 
FXS are diagnosed with autism spectrum disorder (ASD; 
Richards et  al. 2015), although a milder profile of autism 
characteristics is observed than in those with idiopathic 
autism (Moss et al. 2013).
Individuals with FXS are more likely to meet criteria 
for an anxiety disorder compared to individuals with Wil-
liams syndrome, heterogeneous intellectual disability, and 
to the general population. Cordeiro et  al. (2011) reported 
that 86.2% of males with FXS met criteria for one anxiety 
disorder, and 60.3% met criteria for multiple disorders on 
an informant interview based on DSM-IV criteria. Specific 
phobia and social phobia were most commonly reported; 
64.9 and 60.3% respectively. These phobias occurred more 
frequently in those meeting criteria for an ASD, but this 
was not statistically significant. An additional diagnosis of 
ASD, however, was associated with selective mutism; the 
third most commonly reported anxiety disorder in males 
with FXS. The overall figures for anxiety reported by Cord-
eiro et  al. (2011) are similar to those reported by Bailey 
et  al. (2008), in which parental reports demonstrated that 
70% of males with FXS had received a formal diagnosis of 
anxiety or were being treated for anxiety symptoms.
Cordeiro et  al. (2011) reported that participants with 
FXS demonstrated significantly higher rates of anxiety dis-
order than individuals with idiopathic intellectual disabil-
ity and individuals with Williams syndrome. This literature 
highlights the heightened prevalence of anxiety in individu-
als with FXS compared to that of other syndrome groups 
and those with idiopathic intellectual disability, suggesting 
that anxiety is a core phenotypic feature of FXS. The pre-
sent study aims to contribute to this literature by investigat-
ing anxiety in FXS at a symptom-level.
Cornelia de Lange Syndrome
CdLS affects approximately 1 in 40,000 live births (Beck 
1976) and is associated with intellectual disability, as well 
as specific physical characteristics including distinctive 
facial features and limb abnormalities. CdLS is caused pri-
marily by a deletion in the NIPBL gene located on chromo-
some 5 (Gillis et al. 2004; Krantz et al. 2004; Miyake et al. 
2005), with fewer cases being caused by mutations on the 
SMC3 gene on chromosome 10 (Deardorff et al. 2007), the 
SMC1A gene (Musio et al. 2006), the RAD21 gene (Minor 
et al. 2014), and the HDAC8 gene (Deardorff et al. 2012). 
Similarly to FXS, CdLS is associated with an increased 
risk of ASD with current prevalence estimates around 43% 
(Richards et  al. 2015). In addition, and similar to FXS, 
individuals show a subtly different profile of autism symp-
tomatology with more impairment in social interaction and 
communication than in restricted and repetitive behavior 
(Moss et al. 2013).
Anxiety has been reported in between 10 and 64% of 
individuals with CdLS (Basile et  al. 2007; Berney et  al. 
1999; Gualtieri 1991; Kline et  al. 2007), and existing lit-
erature suggests that this increases with age (Basile et  al. 
2007; Collis et  al. 2006; Liu and Krantz 2009) and IQ 
(Basile et al. 2007). Although anxiety has been reported in 
CdLS, the symptomatology associated with specific types 
of anxiety disorder has not yet been extensively investi-
gated in this population.
Social anxiety has been studied independently of other 
types of anxiety disorder in CdLS and evidence suggests 
that there may be heightened levels of social anxiety when 
individuals are presented with particular social demands, 
such as communication (Richards et al. 2009). Collis et al. 
(2006) found that behavioral indicators of social anxiety 
were reported to occur in 75–100% of individuals. This is 
in agreement with observations of behavioral markers of 
social anxiety in CdLS, such as being shy and quiet, and 
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high levels of selective mutism (Goodban 1993; Kline et al. 
2007; Moss et al. 2016).
Rubinstein–Taybi Syndrome
RTS is a multiple congenital anomaly syndrome affecting 
approximately one in 100,000–125,000 live births and is 
caused by mutations, breakpoints, and microdeletions on 
chromosome 16p13.3, or by mutations in the E1A Binding 
Protein, P300, or CREB-binding protein (Hennekam 2006; 
Lacombe et  al. 1992; Petrif et  al. 1995; Roelfsema et  al. 
2005).
Levitas and Reid (1998) reported that 31% of 13 indi-
viduals with RTS were diagnosed with a tic/obsessive 
compulsive disorder. In support of this, Stevens et  al. 
(2011) reported that 31% of individuals with RTS had 
received a psychiatric diagnosis, and that most of these 
were for obsessive compulsive disorder, anxiety, or depres-
sion. Item-level analysis revealed that 33% of participants 
were described as having “unreasonable” fears or anxi-
ety. However, the questionnaire used was not standardised 
or validated. Rather, it consisted of ‘yes or no’ answers to 
140 questions about behavior, independence, education 
and medical problems, limiting the extent to which strong 
conclusions can be drawn. When comparing anxiety-like 
symptoms in those with RTS to those without, internalizing 
behavioral problems including anxiety have been reported 
to be comparable to a group matched for developmental 
level, age and gender (Galéra et al. 2009).
Scores on a measure of anxiety/depression were found 
to be higher in older compared to younger individuals with 
RTS (Yagihashi et  al. 2012). The scores were still in the 
typical range, although they approached borderline clinical 
cut-off in the older participants. In contrast, a measure of 
internalizing, which includes features of anxiety, remained 
constant over the two age groups. Scores on this subscale 
were within the borderline clinical cut-off range for older 
participants with RTS. Item level analyses revealed that 
37.5% of younger participants and 64.5% of older par-
ticipants were reported as ‘too fearful or anxious’. Simi-
larly, 31.3% of the younger participants and 67.7% of the 
older participants were reported as ‘nervous, high-strung, 
or tense’. These results suggest that although anxiety is 
reported in individuals with RTS, it may not be of clinical 
significance.
Previous research has explored the prevalence of psychi-
atric disorders in individuals with RTS, which has revealed 
mixed results. Although these studies provide useful infor-
mation, the research is limited by small sample sizes and a 
lack of a comparison groups. Whilst some of these studies 
have highlighted the presence of anxiety in individuals with 
RTS, exploration of the symptomatology associated with 
sub-types of anxiety in this population is warranted.
Summary and Aims
In summary, evidence suggests the presence of anxiety in 
individuals with FXS, CdLS and RTS. However, knowl-
edge of the symptoms associated with different types of 
anxiety in these groups, which is important for targeted 
interventions, is limited. Furthermore, cross syndrome 
comparisons of anxiety in these populations have not yet 
been conducted. These comparisons have the potential to 
delineate the relationship between anxiety symptomatol-
ogy, the presence of a particular genetic syndrome, and 
intellectual disability, which are important factors associ-
ated with heightened anxiety. Finally, the phenomenology 
of anxiety in comparison to individuals with and with-
out diagnosed anxiety disorders has not been extensively 
explored in these populations.
Measuring anxiety in individuals with an intellec-
tual disability poses a challenge. Tools typically used to 
assess anxiety include psychiatric interviews, clinical rat-
ing scales, and self- and parent-report measures (Bern-
stein et al. 1996). These often rely on the individual that is 
experiencing anxiety to self-identify and report symptoms, 
which may not be possible for people with limited verbal 
abilities. The diagnosis of anxiety disorders is based on the 
presence and severity of clusters of symptoms. The present 
study aims to enhance understanding of anxiety in indi-
viduals with FXS, CdLS and RTS by investigating anxiety 
at this symptom-level. Symptom-based approaches have 
important implications for assessment, understanding the 
experiences of an individual with anxiety, and effectiveness 
of treatments (see Watson 2009 for a review). This is par-
ticularly important given the difficulties in applying some 
elements of the diagnostic criteria of anxiety to individuals 
with an intellectual disability, and the resultant underdiag-
nosis (see Cooray and Bakala 2005 for a review).
Data are presented on parental reports of anxiety symp-
tomatology using the Spence Child Anxiety Scale-Parent 
Version (SCAS-P; Spence 1999), which provides a contin-
uous measure of anxiety symptoms. Due to the heightened 
prevalence of ASD, particularly in FXS and CdLS, and the 
potential associations between anxiety and ASD, chrono-
logical age and adaptive ability, these associations will be 
investigated. The anxiety disorders investigated in the cur-
rent study are not inclusive of every disorder listed in the 
DSM-5 but do include separation anxiety, generalized anxi-
ety disorder, panic attack and agoraphobia, physical injury 
fears, social phobia and obsessive–compulsive disorder.
The SCAS-P was designed as a parental report measure 
to assess anxiety symptomatology in children. Although 
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the present study investigates symptoms of anxiety in chil-
dren and adults with FXS, CdLS and RTS, a parent-report 
measure designed for children was deemed most appropri-
ate due to the severity and range of intellectual disability in 
these populations. Self-report data, particularly in combi-
nation with other measures, is a valuable source of infor-
mation. However, due to the reliance on understanding and 
labeling emotions for accurate self-report of anxiety, along-
side heightened levels of acquiescence in individuals with 
an intellectual disability (Stancliffe 2000), and the severity 
of intellectual disability of participants in the current study, 
a parental measure was most likely to yield robust data in 
this case.
The data obtained from participants with FXS, CdLS 
and RTS were compared to normative data from typically 
developing participants and normative data from par-
ticipants diagnosed with an anxiety disorder (Nauta et  al. 
2004). Although it was not possible to match the norma-
tive participant samples to the participants with FXS, CdLS 
and RTS due to the rarity of the genetic syndrome groups, 
the normative data serve as a benchmark for comparison, 
which aids interpretation. As existing literature on anxiety 
in these populations is limited, these data provide a strong 
starting point for further research questions and studies to 
be developed.
In this study, we address three primary research ques-
tions: (1) How do individuals with FXS, CdLS and RTS 
differ in their profile of anxiety symptomatology? (2) What 
is the relationship between anxiety and chronological age, 
and anxiety and ASD? (3) How do individuals with FXS, 
CdLS and RTS differ in anxiety symptomatology to typi-
cally developing children and individuals diagnosed with 
anxiety?
Method
Participants
Parents of 19 individuals with FXS (0 female, 
 Mage = 24.19, SD 7.51), 13 individuals with CdLS (7 
female,  Mage = 18.75, SD 9.75), and 27 individuals with 
RTS (17 female,  Mage = 23.55, SD 10.74) completed 
the measures for this study. Participants with FXS were 
recruited through the database held at the Cerebra Cen-
tre for Neurodevelopmental Disorders, University of 
Birmingham. Participants with CdLS and RTS were 
recruited through the Cornelia de Lange Foundation (UK 
and Ireland), and the Rubinstein–Taybi Syndrome UK 
Support Group, respectively. All participants had previ-
ously received a diagnosis of FXS, CdLS, or RTS from a 
pediatrician or clinical geneticist. Participant characteris-
tics are presented in Table 1. Due to documented gender 
differences in FXS, all participants with FXS were male. 
Therefore, participants are not matched on sex. However, 
the three participant groups are comparable for chrono-
logical age, global adaptive behavior, verbal adaptive 
behavior, and severity of autism symptomatology.
Normative data on typically developing individuals 
with and without a diagnosed anxiety disorder (obtained 
from Nauta et  al. 2004) are used in the present study. 
These normative data are from 261 typical controls 
aged 6–18 years  (Mage = 11.5, SD 2.0) and 484 children 
diagnosed with an anxiety disorder aged 6–17  years 
 (Mage = 10.4, SD 2.5).
Measures
The following measures were completed by the partici-
pant’s primary caregiver.
Vineland Adaptive Behavior Scale—Second Edition, 
Survey Interview Form (VABS; Sparrow et al. 2005)
This semi-structured interview was administered to pri-
mary caregivers of participants with FXS, CdLS and RTS, 
in order to assess adaptive behavior in the areas of commu-
nication, daily living skills and socialization. The interview 
yields an Adaptive Behavior Composite (ABC) and stand-
ard scores based on a sample of 3000 children.
Table 1  Participant 
characteristics and comparison 
statistics for participants with 
FXS, CdLS and RTS
Fragile X Cornelia de Lange Rubinstein–Taybi p value for 
comparison(n = 19) (n = 13) (n = 27)
Chronological age (SD) 24.19 (7.51) 18.75 (9.75) 23.55 (10.74) 0.247
Gender % male 100.00 46.15 37.04 <0.001
Adaptive behavior compos-
ite standard score mean 
(SD)
46.05 (16.67) 50.08 (17.50) 43.59 (16.51) 0.522
Verbal adaptive behavior 
standard score mean (SD)
38.47 (19.34) 47.23 (22.02) 42.30 (18.78) 0.470
SCQ total score 17.99 (6.61) 19.60 (6.56) 17.76 (6.06) 0.679
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Social Communication Questionnaire (SCQ; Rutter et al. 
2003)
The SCQ is an informant questionnaire designed to assess 
behaviors associated with ASD such as repetitive behav-
ior, communication and social interaction. The authors of 
the SCQ suggest that a score of 15 or above indicates the 
presence of ASD, whereas a score of 22 or above indicates 
the presence of autism. Internal consistency and concurrent 
validity with the Autism Diagnostic Observation Schedule 
(Lord et al. 1999) are good (Howlin and Karpf 2004).
The Spence Child Anxiety Scale—Parent Version (Spence 
1999)
The SCAS-P is a 38-item informant questionnaire designed 
to assess anxiety symptoms in children. The SCAS-P 
assesses symptomatology associated with the following six 
domains of anxiety: physical injury fears, obsessive–com-
pulsive disorder, separation anxiety, social phobia, panic/
agoraphobia, and generalized anxiety. Psychometric prop-
erties show the scale to significantly differentiate those 
with and without an anxiety disorder (Nauta et  al. 2004). 
In addition, when used with children and adolescents with 
ASD, the SCAS-P demonstrates good to excellent internal 
consistency for the total score, acceptable to good internal 
consistency at a subscale level, and convergent validity 
with the Development Behavior Checklist-Parent Version 
total score and anxiety subscale (Einfeld and Tongue 2002; 
Zainal et  al. 2014). Zainal et  al. (2014) suggested that 
psychometric properties of the SCAS-P are similar when 
the measure is used with children and adolescents with 
and without ASD, based on data reported by Nauta et  al. 
(2004), and that a diagnosis of a neurodevelopmental disor-
der such as ASD does not appear to compromise the valid-
ity of the measure. The measure has also been described as 
robust for use in the ASD population (Wigham and McCo-
nachie 2014).
Procedure
The measures in this study were included in a questionnaire 
pack given to parents and caregivers of participants taking 
part in a larger study on cognitive and social difficulties in 
FXS, CdLS and RTS (Crawford et  al. 2016). Parents and 
carers of participants were given the questionnaire pack 
either at a syndrome support group meeting or during a 
research visit. The questionnaires were either returned on 
the same day or via post following the meeting or visit. The 
VABS was either administered during the research visit or 
over the phone following the meeting or visit.
Data Analysis
All data were subjected to the Shapiro–Wilk test for nor-
mality. Non-parametric tests were used to confirm results 
from parametric tests for data that were not normally dis-
tributed. For consistency, results from parametric tests are 
reported where non-parametric tests revealed the same 
results. Except where mentioned, the alpha level for signifi-
cance was 0.05.
Results
Figure 1 displays the mean scores on each subscale for par-
ticipants with FXS, CdLS and RTS, as well as the mean 
scores from normative data on typically developing chil-
dren and children with an anxiety disorder. The total scores 
on the SCAS-P were: FXS: Mean = 19.71, SD 16.50; 
CdLS: Mean = 27.66, SD 13.08; RTS: Mean = 15.32, SD 
11.05. The total scores on the SCAS-P from normative data 
are: typically developing children: Mean = 14.2, SD 9.7; 
anxiety disorder: Mean = 31.8; SD 14.1 (Nauta et al. 2004). 
The percentage of participants scoring outside of the nor-
mal range, as defined by the mean + 1 standard deviation 
using the national normal data, is displayed in Table 2.
Syndrome Group Comparison
One-way ANOVAs revealed a significant between-groups 
difference in the following subscales of the SCAS-P: sepa-
ration anxiety (F (2, 58) = 6.379, p = 0.003), generalized 
anxiety (F (2, 58) = 3.667, p = 0.032), and total score (F 
(2, 58) = 3.697, p = 0.031). There were no between-groups 
differences in the subscales assessing panic attack and ago-
raphobia, physical injury fears, social phobia, and obses-
sive–compulsive disorder (p > 0.05). Bonferroni post-hoc 
analyses revealed that differences in the separation anxi-
ety subscale were due to participants with CdLS scoring 
higher than participants with FXS (p = 0.038) and RTS 
(p = 0.002). Differences in the generalized anxiety subscale 
were also due to participants with CdLS scoring higher 
than participants with FXS (p = 0.033) and participants 
with RTS (p = 0.006). Finally, differences in the total score 
were due to participants with CdLS scoring higher than 
participants with RTS (p = 0.026).
Relationship Between Anxiety, Chronological Age 
and Autism Symptomatology
Spearman’s rho correlational analyses were conducted for 
each group to investigate whether there was a relationship 
between any subscale on the SCAS-P and chronological 
age, global adaptive behavior, verbal adaptive behavior and 
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autism symptomatology. The alpha level was adjusted to 
0.01 to account for multiple correlations. Significant cor-
relations are depicted in Fig. 2.
For the FXS group, the analyses revealed a positive 
relationship between scores on the obsessive–compulsive 
subscale and chronological age (Fig.  2a;  rs (17) = 0.643, 
p = 0.003), and a negative relationship between scores 
on the obsessive–compulsive subscale and global adap-
tive behavior (Fig.  2b;  rs (17) = −0.597, p = 0.007). For 
the CdLS group, significant positive relationships were 
revealed between chronological age and scores on the panic 
attack and agoraphobia subscale (Fig.  2c;  rs (11) = 0.688, 
p = 0.009), and the obsessive–compulsive subscale 
(Fig.  2a;  rs (11) = 0.785, p = 0.001), and a marginally sig-
nificant positive relationship was revealed between chrono-
logical age and scores on the generalized anxiety disorder 
subscale (Fig. 2d; rs (11) = 0.680, p = 0.011). There were no 
significant correlations between the subscales of the SCAS-
P and participant characteristics for the RTS group.
Comparison to Normative Data
One sample t tests were carried out using the mean and 
standard deviation on each subscale of the SCAS-P for 
each syndrome group in order to compare their data to nor-
mative data for typically developing individuals with and 
without a diagnosed anxiety disorder (obtained from Nauta 
et al. 2004). For children with an anxiety disorder, means 
and standard deviations on each subscale of the SCAS-P 
are also available by the type of anxiety disorder that they 
have been diagnosed with (separation anxiety, generalized 
anxiety, social phobia, panic/agoraphobia, specific phobia 
and OCD). Where possible, for any subscale in which par-
ticipants with FXS, CdLS or RTS scored similarly to the 
group of children with an anxiety disorder, further com-
parisons were made to investigate whether scores remained 
similar when compared to children diagnosed with the sub-
type of anxiety reflected in the subscale of the SCAS-P. For 
example, if participants with FXS did not score differently 
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Fig. 1  The mean scores on each subscale of the SCAS-P for each syndrome group and two normative comparison groups. Error bars represent 
standard deviation, as standard error data were not available for normative data
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Table 2  Summary of comparisons between syndrome groups and 
normative data on subscales of the SCAS-P (< group at the top of 
the table scored lower than the group listed in the column, = no dif-
ference between scores, > group at the top of the table scored higher 
than the group listed in the column)
Significant associations between subscale scores and participant characteristics (+ positive correlation; − negative correlation), and the percent-
age of participants scoring above the normal range, are also noted. Significant differences are indicated in bold
TD typically developing, AD anxiety diagnosis
a Marginally significant result
Fragile X (FXS) Cornelia de Lange (CdLS) Rubinstein–Taybi (RTS)
Separation anxiety <CdLS >FXS =FXS
=RTS >RTS <CdLS
=TD >TD =TD
<AD =AD <AD
Percentage of participants scoring 
above normal range
26.3% 61.5% (50% of males, 71.4% of 
females)
14.8% (20% of males, 11.8% of 
females)
Social phobia =CdLS =FXS =FXS
=RTS =RTS =CdLS
=TD =TD <TD
=AD <AD <AD
Percentage of participants scoring 
above normal range
15.8% 7.7% (16.7% of males, 0% of females) 3.7% (10% of males, 0% of females)
Generalized anxiety <CdLS >FXS =FXS
=RTS >RTS <CdLS
=TD >TD =TD
<AD =AD <AD
Percentage of participants scoring 
above normal range
26.3% 61.5% (33.3% of males, 85.7% of 
females)
18.5% (30% of males, 11.8% of 
females)
Trajectory +Agea
Panic/Agoraphobia =CdLS =FXS =FXS
=RTS =RTS =CdLS
>TDa >TD >TD
=AD =AD =AD
Percentage of participants scoring 
above normal range
47.4% 53.8% (50% of males, 57.1% of 
females)
37% (50% of males, 29.4% of females)
Trajectory +Age
Physical injury fears =CdLS =FXS =FXS
=RTS =RTS =CdLS
=TD >TD =TD
=AD =AD <AD
Percentage of participants scoring 
above normal range
36.8% 46.2% (33.3% of males, 57.1% of 
females)
22.2% (40% of males, 11.8% of 
females)
Obsessive–compulsive disorder =CdLS =FXS =FXS
=RTS =RTS =CdLS
=TD =TD >TD
=AD =AD =AD
Percentage of participants scoring 
above normal range
36.8% 38.5% (33.3% of males, 42.9% of 
females)
40.7% (60% of males, 29.4% of 
females)
Trajectory +Age
−Adaptive behavior
+Age
Total score =CdLS =FXS =FXS
=RTS >RTS <CdLS
=TD >TD =TD
<AD =AD <AD
Percentage of participants scoring 
above normal range
36.8% 53.8% (50% of males, 57.1% of 
females)
18.5% (30% of males, 11.8% of 
females)
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to the children with an anxiety disorder on the social pho-
bia subscale of the SCAS-P, their scores were then com-
pared to scores of children diagnosed with social phobia. 
As a specific type of anxiety disorder does not represent the 
physical injury fears subscale, the above comparisons were 
not conducted when there were no differences between 
participants with FXS, CdLS or RTS and children with an 
anxiety disorder on the physical injury fears subscale. Due 
to multiple analyses, the p-value was adjusted to 0.01.
Fragile X Syndrome
In comparison to normative data collected from typically 
developing participants, participants with FXS only scored 
marginally higher on the panic/agoraphobia subscale (t 
(279) = 2.570, p = 0.01). On all other subscales, no signifi-
cant differences were revealed between participants with 
FXS and normative data collected from typically develop-
ing participants (all p > 0.01).
Scores did not differ between children diagnosed with 
an anxiety disorder and participants with FXS on the social 
phobia subscale (t (502) = −2.170, p = 0.03), the panic 
attack/agoraphobia subscale (t (502) = 0.019, p = 0.985), 
the physical injury fears subscale (t (502) = −0.706, 
p = 0.481), and the obsessive–compulsive disorder subscale 
(t (502) = −2.033, p = 0.043). For all other subscales and 
the total score, participants with FXS scored significantly 
lower than the children diagnosed with an anxiety disorder 
(all p < 0.01).
Cornelia de Lange Syndrome
Participants with CdLS scored higher than a normative 
sample of typically developing children on the separation 
anxiety subscale (t (273) = 4.671, p < .001), the generalized 
anxiety subscale (t (273) = 2.940, p = 0.004), the panic/ago-
raphobia subscale (t (273) = 3.284, p = 0.001), the physical 
injury fears subscale (t (273) = 3.009, p = 0.003), and on the 
total score (t (273) = 3.677, p < 0.001). No differences were 
revealed between participants with CdLS and the norma-
tive sample of typically developing children on the social 
phobia subscale and the obsessive–compulsive disorder 
subscale (all p < 0.01).
No differences were revealed between participants with 
CdLS and children diagnosed with an anxiety disorder 
on any subscale (all p > 0.01), except on the social pho-
bia subscale, where participants with CdLS scored sig-
nificantly lower than children with an anxiety disorder (t 
(495) = −0.704, p < 0.001). No differences were revealed 
between participants with CdLS and children diagnosed 
with generalized anxiety disorder on the generalized anxi-
ety subscale (t (175) = −1.411, p = 0.160).
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Fig. 2  The relationship between participant characteristics and the SCAS-P for each syndrome group
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Rubinstein–Taybi Syndrome
Participants with RTS scored significantly lower than the 
normative typically developing sample on the social pho-
bia subscale (t (287) = −5.662, p < 0.001), and significantly 
higher than typically developing children on both the panic 
and agoraphobia subscale (t (287) = 3.163, p = 0.002) and 
the OCD subscale (t (287) = 2.633, p = 0.009). Scores 
between typically developing participants and participants 
with RTS did not differ on the other subscales of separation 
anxiety, generalized anxiety, physical injury fears, and the 
total score (all p > 0.01).
Participants with RTS did not evidence significantly dif-
ferent scores to children with an anxiety disorder on the 
subscales of panic/agoraphobia and obsessive–compulsive 
disorder (t (509) = −0.587, p = 0.557), but they did evi-
dence lower scores than children diagnosed with obses-
sive–compulsive disorder (t (43) = −5.337, p < 0.001). For 
all other subscales, participants with RTS scored signifi-
cantly lower than the children diagnosed with an anxiety 
disorder (all p < 0.01). The results from the comparative 
and correlational analyses are presented in Table 2.
Discussion
This study conducted subscale level analysis using the 
SCAS-P to identify similarities and differences in the pro-
file of anxiety symptomatology in individuals with FXS, 
CdLS and RTS. The relationship between anxiety and 
participant characteristics was also examined. In addition, 
subscale scores on the SCAS-P were compared to norma-
tive data available from typically developing children, chil-
dren diagnosed with an anxiety disorder, and, where pos-
sible, children diagnosed with the specific anxiety disorder 
reflected in each subscale of the informant report measure.
To summarise, participants with CdLS scored higher 
than participants with FXS and RTS on the separation 
anxiety and generalized anxiety subscales of the SCAS-P. 
In addition, there were no differences between participants 
with FXS and children diagnosed with an anxiety disorder 
on the social phobia, panic attack/agoraphobia, obsessive-
compulsive disorder, or the physical injury fears subscales. 
There were also no differences between participants with 
RTS and children diagnosed with an anxiety disorder 
on the panic attack/agoraphobia and obsessive–compul-
sive disorder subscales. Finally, there were no differences 
between participants with CdLS and children diagnosed 
with an anxiety disorder on the separation anxiety, general-
ized anxiety, panic attack/agoraphobia, physical injury and 
obsessive–compulsive disorder subscales, and on the total 
score. When compared to children diagnosed with specific 
types of anxiety disorder reflected in the subscales of the 
SCAS-P, only the scores from participants with CdLS on 
the generalized anxiety subscale could not be differentiated 
from those diagnosed with generalized anxiety disorder. 
It is important to note that the genetic syndrome groups 
were not matched to the typically developing children and/
or children diagnosed with an anxiety disorder. Therefore, 
these normative data should be viewed as a benchmark 
comparison to aid interpretation of the results from the 
genetic syndrome groups.
Positive associations were reported between the chron-
ological age of participants with CdLS and their scores 
on the generalized anxiety, panic attack/agoraphobia and 
obsessive–compulsive disorder subscales, supporting exist-
ing literature indicating that heightened anxiety may coin-
cide with increasing age in this group (Basile et al. 2007; 
Collis et  al. 2006). The associations between anxiety and 
chronological age were not seen in the RTS group and only 
emerged in the FXS group on the obsessive–compulsive 
disorder subscale. In addition, there was no relationship 
between autism symptomatology and anxiety for any par-
ticipant group. This supports previous research indicating 
no difference in anxiety symptomatology in participants 
with FXS and an additional diagnosis of ASD compared 
to those without an additional diagnosis (Cordeiro et  al. 
2011).
The findings of this study support previous literature 
demonstrating elevated levels of social phobia, panic disor-
der with agoraphobia, and obsessive–compulsive disorder 
in individuals with FXS compared to a matched compari-
son group (Cordeiro et al. 2011), and extends this by sug-
gesting the severity of symptomatology of these disorders 
are similar in FXS to those seen in individuals diagnosed 
with an anxiety disorder. In addition, heightened levels of 
specific phobia have been reported in FXS (Cordeiro et al. 
2011). Whilst the measure utilized in the present study 
did not assess specific phobia, it did demonstrate elevated 
scores on the ‘physical injury fears’ subscale, which may 
be considered a specific phobia. Previous research has also 
demonstrated higher rates of generalized anxiety disorder 
in FXS (Cordeiro et  al. 2011), a finding not replicated in 
the present study. A potential reason for these contrasting 
findings is the utilization of different methodologies to 
study anxiety diagnosis versus anxiety symptomatology. 
For example, in the present study, a parent-report measure 
was used to delineate the profile and investigate the symp-
tomatology of different subtypes of anxiety, whereas the 
study conducted by Cordeiro et al. (2011) investigated the 
prevalence rates of individuals with FXS meeting diagnos-
tic criteria for a range of anxiety disorders. It is important 
to note that, in the present study, the FXS group did not 
score higher on any subscales of the measure used than 
the other two genetic syndrome groups matched for adap-
tive behavior and chronological age. Therefore, the higher 
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levels of social phobia, panic with agoraphobia, physical 
injury fears, and obsessive–compulsive disorder may be 
related to developmental ability, although the comparison 
groups have also been associated with anxiety both in the 
present study and in previous literature.
The findings reported here document the severity and 
breadth of anxiety symptomatology in individuals with 
CdLS. In particular, individuals with CdLS demonstrated 
higher levels of generalized anxiety disorder and separation 
anxiety than both typically developing children and indi-
viduals with different genetic syndromes associated with 
intellectual disability. For these two types of anxiety disor-
der, no differences were revealed between individuals with 
CdLS and those diagnosed with an anxiety disorder, high-
lighting the severity of anxiety disorders in this population. 
Aside from social phobia, participants with CdLS demon-
strated similar levels of all other types of anxiety disorders 
measured here to normative data obtained from individuals 
diagnosed with an anxiety disorder, thus highlighting the 
broad nature of anxiety disorder in this group. The results 
from the present study support previous literature sug-
gesting obsessive–compulsive features in individuals with 
CdLS (Kline et al. 2007), and extends this to indicate the 
range of additional anxiety disorders present in this group.
In the present study, individuals with RTS did not dem-
onstrate heightened levels of anxiety in comparison to the 
other genetic syndrome groups. However, levels of panic 
attack/agoraphobia and obsessive–compulsive disorder 
were reported to be higher in RTS than typically develop-
ing children, and similar to those diagnosed with an anxi-
ety disorder. This supports previous literature highlight-
ing the presence of obsessive–compulsive features in this 
population (Levitas and Reid 1998; Stevens et al. 2011). It 
is important to note that repetitive behavior is a well-doc-
umented characteristic of RTS (Waite et al. 2015). There-
fore, the elevated scores on the obsessive–compulsive dis-
order subscale may reflect heightened levels of repetitive 
behavior, rather than the full range of symptomatology 
associated with obsessive-compulsive disorder.
The results reported here highlight that different types 
of anxiety disorder may be problematic for individuals 
with different genetic syndromes. However, it is possible 
that whilst there may be similarities in the ways in which 
these anxiety disorders manifest behaviorally in individu-
als with genetic syndromes and the general population, 
differences may exist between these populations in the 
mechanisms subserving these behaviors. This notion is 
supported by the conceptual differences in anxiety that 
have been reported between individuals with and with-
out ASD (Kerns et al. 2014). In particular, it may be the 
case that ASD-related impairments, such as adherence 
to routine, may contribute to the anxiety in individuals 
with ASD that are not consistent with anxiety diagnostic 
categories such as intolerance to  uncertainty (Rodg-
ers et  al. 2016). In the current study, elevated levels of 
panic attack and agoraphobia symptomatology in indi-
viduals with FXS may be related to hypersensitivity of 
sensory stimuli, a common feature of this genetic syn-
drome (Baranek et  al. 2009; Cornish et  al. 2008). This 
behavioral characteristic may contribute to anxiety in set-
tings where sensory input is heightened, such as crowded 
places like shopping centers and busy playgrounds. The 
presence of anxiety in crowded places features as an 
item of the panic attack and agoraphobia subscale of the 
SCAS-P. Further understanding the underlying mecha-
nisms of anxiety disorder in neurodevelopmental disor-
ders is paramount to developing targeted interventions.
The results of the present study should be considered in 
light of some limitations. First, whilst the genetic syndrome 
groups were statistically comparable on chronological age, 
these groups were not matched to the samples from which 
normative data were obtained. Therefore, comparisons 
between the syndrome groups and normative data groups 
should be treated with caution and future research should 
conduct comparisons with matched groups. Second, the 
SCAS-P was designed to measure anxiety symptomatol-
ogy in young, typically developing children. There is a 
lack of suitable measures of anxiety that are designed for 
children and adults with an intellectual disability and fur-
ther research is required to develop such measures. Despite 
the limitations, this study conducted an initial investiga-
tion into the profile of anxiety disorder and has reported 
elevated levels of symptoms associated with different sub-
types of anxiety in individuals with three different genetic 
syndromes. This requires further investigation using diag-
nostic parent report measures alongside behavioral obser-
vation and clinical consultation. Extrapolating these pheno-
typic differences is crucial to further understand the nature 
and severity of anxiety that people with these genetic syn-
dromes experience.
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